Joyce Lubbers
Overview
Explore the profile of Joyce Lubbers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
454
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dusoswa S, Verhoeff J, van Asten S, Lubbers J, van den Braber M, Peters S, et al.
Front Immunol
. 2024 Feb;
15:1343484.
PMID: 38318180
Background: Glioblastomas manipulate the immune system both locally and systemically, yet, glioblastoma-associated changes in peripheral blood immune composition are poorly studied. Age and dexamethasone administration in glioblastoma patients have been...
2.
Keumatio Doungtsop B, Nardini E, Kalay H, Versteeg S, Lubbers J, van Barneveld G, et al.
J Allergy Clin Immunol Glob
. 2024 Jan;
3(1):100193.
PMID: 38187864
Background: House dust mite extract-based allergen immunotherapy (AIT) to treat house dust mite allergy is substantially effective but still presents some safety and efficacy concerns that warrant improvement. Several major...
3.
Lubbers J, Eveline Li R, Gorki F, Bruijns S, Gallagher A, Kalay H, et al.
Immunother Adv
. 2022 Aug;
1(1):ltab012.
PMID: 35919745
Objective: We here investigated whether α2-3sia, that bind immune inhibitory Siglec receptors, would alter signaling and reprogramming of LPS-stimulated human monocyte-derived DCs (moDCs). Methods And Results: Transcriptomic analysis of moDCs...
4.
Stolk D, de Haas A, Vree J, Duinkerken S, Lubbers J, van de Ven R, et al.
Front Immunol
. 2020 Jun;
11:990.
PMID: 32536918
In this study we developed a liposome-based vaccine containing palmitoylated synthetic long peptides (SLP) and alpha galactosylceramide (αGC) to specifically target dendritic cells (DC) for activation of both innate (invariant...
5.
Zaal A, Li R, Lubbers J, Bruijns S, Kalay H, van Kooyk Y, et al.
Front Immunol
. 2020 Mar;
11:305.
PMID: 32161592
Many tumors display alterations in the biosynthetic pathways of glycosylation, resulting in increased expression of specific tumor-associated glycan structures. Expression of these altered glycan structures is associated with metastasis and...
6.
Lubbers J, Rodriguez E, van Kooyk Y
Front Immunol
. 2018 Dec;
9:2807.
PMID: 30581432
One of the key features of the immune system is its extraordinary capacity to discriminate between self and non-self and to respond accordingly. Several molecular interactions allow the induction of...
7.
Machado Y, Duinkerken S, Hoepflinger V, Mayr M, Korotchenko E, Kurtaj A, et al.
J Control Release
. 2017 Sep;
266:87-99.
PMID: 28919557
Due to its unique immunological properties, the skin is an attractive target tissue for allergen-specific immunotherapy. In our current work, we combined a dendritic cell targeting approach with epicutaneous immunization...
8.
Lubbers J, van Beers-Tas M, Vosslamber S, Turk S, de Ridder S, Mantel E, et al.
Arthritis Res Ther
. 2016 Sep;
18(1):205.
PMID: 27629388
Background: Multiple lymphocyte subsets like T and B cells have been connected to joint infiltration and inflammation in rheumatoid arthritis (RA). Identification of leucocyte subsets that are dysregulated in arthritis...
9.
de Jong T, Lubbers J, Turk S, Vosslamber S, Mantel E, Bontkes H, et al.
Arthritis Res Ther
. 2016 Jul;
18:165.
PMID: 27411379
Background: The type I interferon (IFN) signature in rheumatoid arthritis (RA) has shown clinical relevance in relation to disease onset and therapeutic response. Identification of the cell type(s) contributing to...
10.
Lubbers J, Vosslamber S, van de Stadt L, van Beers-Tas M, Wesseling J, von Blomberg B, et al.
Ann Rheum Dis
. 2015 May;
74(9):1786-8.
PMID: 26019192
No abstract available.